The lysosome-associated transporter proton-coupled amino acid transporter 1 (PAT1) promotes nutrient recycling through releasing luminal amino acids into the cytosol. Using HEK293 cells expressing an EGFP-tagged PAT1 (EGFP-PAT1) as a model, we identified a consensus tyrosine-based targeting signal in the cytosolic N-terminal region of PAT1, which facilitates its expression on the lysosome. Interestingly, this signal can be removed via protein cleavage in an amino acid-sensitive manner. The cleavage is suppressed upon amino acid starvation and is induced by amino acid replenishment. However, amino acid deficiency does not suppress the cleavage of amino acidbinding mutants of EGFP-PAT1. Our data support a mechanism, whereby amino acid binding induces PAT1 cleavage to remove a targeting signal, thus suppressing the expression of PAT1 on the lysosome.
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The proton-coupled amino acid transporter 1 (PAT1) is the founding member of the solute carrier protein family 36 (SLC36) that also contains PAT2-4 [1, 2] . PAT1 is a low-affinity, high-capacity transporter that moves a broad range of substrates across membranes in a pH-dependent manner [3] [4] [5] [6] [7] [8] [9] . PAT1 was initially identified in rat and termed the lysosomal amino acid transporter 1 (LYAAT1) [3] . Since then, it has been characterized to be a widely expressed protein in vertebrates, including humans [6, 9] , mice [4] and rabbits [10] . PAT1 is highly expressed in the small intestinal epithelium of both humans and rats, and is involved in nutrient absorption [6, 9] . In rat neuronal cells, it is responsible for the delivery of neurotransmitters [5] . In horse skin, PAT1 is associated with the pigmentation process [11] . Within the cell, PAT1 is usually located on the lysosome and cell surface [3, 5, 6, 9] ; but it is also expressed on axons and secretory vesicles in rat neuronal cells [5] and in podosomes in both human macrophages and mouse NIH3T3 cells [12] . In rat smooth muscle cells, it is even expressed in nuclei [13] . These findings probably indicate that the functions of PAT1 are closely linked with its subcellular localization. However, the molecular mechanisms regulating the targeting of PAT1 remain largely undefined.
Abbreviations 4EBP1, eukaryotic translation initiation factor 4E-binding protein 1; LAMP1, lysosome-associated membrane protein 1; mTORC1, mechanistic target of rapamycin complex 1; p4EBP1, phosphor-ribosomal protein 4EBP1 (at S65); PAT1, proton-coupled amino acid transporter 1; pS6K1, phosphor-ribosomal protein S6 kinase 1 (at T389); S6K1, ribosomal protein S6 kinase 1. In response to available nutrients, such as amino acids, cells can adjust their metabolism and growth via the mechanistic target of rapamycin complex 1 (mTORC1) signalling pathway [14] . Recent research reveals that lysosome is a key organelle for mTORC1 activation. It is becoming clear that amino acids stored within the lysosome are a direct signal to recruit and activate mTORC1 on the lysosomal surface [15, 16] . Consistent with this model, reducing the lysosomal amino acids, via either permeabilizing the lysosomal membrane or overexpressing PAT1, inhibits mTORC1 in HEK293 cells after an amino acid restimulation treatment [17] . However, there is other research showing that mTORC1 activity is not decreased in HEK293 cells upon PAT1 overexpression [18] . In a previous study [19] , we attempted to provide an explanation for this discrepancy based on a surprising finding that the lysosomal expression of PAT1 was dynamic. We showed that it was increased by amino acid deprivation and decreased once amino acids were replenished. Accordingly, short-term exposure to amino acids (e.g. < 10 min) was not sufficient to relocate the excessive lysosome-associated PAT1 and activate mTORC1 [17, 19] . If the amino acid exposure was extended for a longer time (e.g. > 30 min), the lysosome-associated PAT1 is reduced and mTORC1 is reactivated by the elevated lysosomal amino acids [18] . These results support a view that controlling the abundance of lysosomal PAT1 is an important mechanism in nutrient homoeostasis and mTORC1 regulation. However, an important question that remains to be explored is how amino acids can feedback to prevent the accumulation of PAT1 on the lysosomal surface.
During the analysis of EGFP-PAT1, which is a chimeric PAT1 protein, we found that it could be proteolysed to remove the cytosolic N-terminal domain in HEK293 cells. Within the cleaved PAT1 region (< 56 amino acids), we identified a consensus tyrosine-based lysosomal targeting signal, 38 YQRF
41
. Disruption of this signal, by replacing the critical tyrosine residue with alanine (Y38A), decreased EGFP-PAT1 expression on the lysosome, suggesting that the YQRF motif can facilitate the targeting of EGFP-PAT1 to the lysosome. Interestingly, the cleavage of EGFP-PAT1 was sensitive to nutrient status: it was suppressed by amino acid deficiency and induced by amino acid replenishment. We further demonstrated that amino acids did not induce the cleavage via mTORC1. Instead, it seems that the direct interaction between amino acids and EGFP-PAT1 is critical to induce the cleavage reaction. Our data support a mechanism through which amino acids may suppress the expression of PAT1 on lysosomes by inducing protein cleavage to remove a targeting signal.
Materials and methods

Cell culture, plasmids constructions and stable cell lines selection
The cells were normally cultured in complete medium: Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 8% FBS, 4 mM L-glutamine, 4500 mgÁL À1 glucose, and sodium pyruvate, at 37°C and 5% CO 2 . All the plasmids, including these encoding the full-length PAT1s, the Y38A point mutation and the truncated PAT1s were generated through PCR and inserted into either pEGFP-C1 or -N1 vector (for PAT1-EGFP). The genes encoding myc-PAT1 or myc-PAT1 Y38A were inserted into the pcDNA3.1
vector. Stable cell lines were obtained by selection with G418 (Invitrogen, Carlsbad, CA, USA). 
Antibodies and chemicals
Amino acid starvation and refreshment
The cells were cultured in complete medium and were allowed to grow to approximately 80% confluence. For the starvation treatment, cells were washed with PBS twice, followed by incubation with amino acid-free RPMI-1640 medium (US Biological, R8999-04A, Swampscott, MA, USA) for the indicated period of time. For replenishment with amino acids, the RPMI-1640 was replaced with either the complete medium or RPMI-1640 supplemented with single amino acid at a concentration of 4 mM. The most abundant amino acid in the complete medium is glutamine, whose concentration is 4 mM.
Lysosome purification and cell surface biotinylation
Lysosomes were isolated using LYSISO1 (Sigma Aldrich). Briefly, the cells were collected by centrifugation at 600 g for 5 min (~1.5 9 10 8 cells in total). The following steps were carried out on ice. The cells were resuspended in 200 lL of extraction buffer and were homogenized with five gentle strokes in a 2-mL Dounce glass tissue grinder. After centrifugation at 1000 g for 10 min, the supernatant was collected, and the pellet was homogenized for another four rounds. The supernatants from all homogenizations were then collected (~1 mL) and centrifuged at 20 000 g for 20 min. The pellet was resuspended in 50 lL of RIPA lysis buffer to yield the lysosome fraction. The biotinylation of the membrane proteins were performed essentially as described elsewhere [20, 21] . Cells grown on a 90-mm dish (three dishes,~1.5 9 10 8 cells)
were collected. In the final step, the beads was incubated with 20 lL of the lysis buffer plus 30 lL of the SDS loading buffer and the supernatants were processed for western blot.
Cell lysis and western blot
The cells were washed once in ice-cold 19 PBS, harvested and lysed in with RIPA lysis buffer (Nanjing KeyGen Biotech, Nanjing, China) containing 25 mM Tris-HCl pH 7.6, 150 mM NaCl, 0.5 mM PMSF, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS, protease and phosphatase inhibitors (Roche, Mannheim, Germany). The lysates were cleared by centrifugation at 20 000 g for 15 min at 4°C and were suspended with SDS loading buffer. After that, the samples were either boiled for 5 min or placed at 25°C for 2 h (nonboiled condition). The protein concentration was measured by the bicinchoninic acid assay. For western blot, the samples were separated by SDS/PAGE and were transferred to poly(vinylidene difluoride) (PVDF). The PVDF membranes were blocked in 5% nonfat milk, incubated with primary antibodies followed by HRP-conjugated secondary antibodies. Immunoreactivity was detected using ECL and chemiluminescence reagents (Bio-Rad, Hercules, CA, USA). The quantification assays were performed using the Bio-Rad Quantity One software (v4.6.6; Bio-Rad). The results are presented as the mean AE SEM, based on at least three independent experiments. The statistical analyses were performed with Student's unpaired t-test using SPSS software (Version 17.0; SPSS, Inc., Chicago, IL, USA). P < 0.05 was considered statistically significant.
Results
EGFP-PAT1 can be cleaved to remove the cytosolic N-terminal domain in HEK293 cells
The human PAT1 gene was predicted to encode an 11-pass transmembrane protein harbouring an N-terminal cytosolic tail and a C-terminal extracellular tail ( Fig. 1A ) [22] [23] [24] . In a previous work, we generated stable HEK293 cell lines expressing EGFP-PAT1, which is a chimeric protein containing an N-terminal EGFP tag [19] . Using these cells as a model, we showed that overexpression of EGFP-PAT1 decreased mTORC1 activity following an amino acid depletion and replenishment treatment [19] . A similar result was obtained in Sabatini's lab by analysing HEK293 cells that transiently expressed the myc-tagged PAT1, myc-PAT1 [17] . This implies that the N-terminal EGFP tag has little influence on PAT1 functions at least with regard to mTORC1 regulation. We performed western blot experiment to examine the expression of EGFP-PAT1 in stable cell lines using a monoclonal anti-GFP antibody. To denature the proteins thoroughly and to prevent protein degradation, cell lysates were boiled for 5 min before they were separated by SDS/PAGE. In the results, we consistently detected three protein bands in several stable EGFP-PAT1 cell lines. These include an expected 80 kDa band corresponding to full-length EGFP-PAT1, a large band (> 120 kDa) representing EGFP-PAT1 aggregates (formed via hydrophobic interactions at high temperatures, ref 20) , and a short~32 kDa band with an unknown nature (Fig. 1B, lane 2-4) . As a control, we observed a single band corresponding to EGFP (~27 kDa) in the cells transiently transfected with a pEGFP-C1 vector (Fig. 1B, lane 1) . We also analysed the protein samples without the boiling treatment. In this case, the aggregation of EGFP-PAT1 was suppressed and we observed a strong signal from the~80 kDa EGFP-PAT1 (Fig. S1 ). Meanwhile, we still detected the~32 kDa fragment, suggesting that it was not generated during sample preparation. We noticed that proteins in the crude cell lysates were unstable without boiling treatment, because the signal from the~32 kDa band was relatively weak, and there were other weak protein bands that may represent partial degradation products of EGFP-PAT1. In the following experiments, we mostly analysed boiled samples in order to preserve the~32 kDa fragment. Taken together, we concluded that some EGFP-PAT1 proteins were cleaved to remove a short PAT1 fragment with approximately dozens of amino acids (~5 kDa) in HEK293 cells.
To explore if PAT1 can be cleaved at its C-terminus, we placed EGFP downstream of PAT1 and generated cell lines that stably expressed PAT1-EGFP. In western blot experiments, the anti-GFP antibody recognized PAT1-EGFP in both monomeric (~80 kDa) and aggregated forms (> 120 kDa), and no other protein fragments could be readily detected (Fig. 1C) . We constructed an EGFP-PAT1-DsRedT4 transgene, in which EGFP and DsRedT4 were attached to the Nand C terminus of PAT1 respectively. This tansgene was transiently expressed in HEK293 cells and whole lysate were analysed by western blot using either anti-GFP or -RFP antibody. As anticipated, both antibodies recognized the monomers (~110 kDa) and aggregates (> 120 kDa) of EGFP-PAT1-DsRedT4, and the GFP antibody recognized an additional~32 kDa fragment (Fig. 1D) . Based on these results, we propose that PAT1 is mainly cleaved at its N terminus in HEK293 cells.
We obtained a polyclonal anti-PAT1 antibody from Santa Cruz Biotechnology (sc-368553). According to the supplier's description, this antibody was raised against a peptide corresponding to the N-terminal cytosolic tail of human PAT1 (residue 1-56). In western blot experiments, this antibody did not produce a clean signal around the predicted size of endogenous PAT1 (~53 kDa); but it clearly recognized the overexpressed PAT1 proteins (Fig. 1E) . Importantly, this antibody also recognized the~32 kDa fragment in cells expressing EGFP-PAT1 or EGFP-PAT1-DsRedT4, but not in cells expressing PAT1-EGFP. To detect the short peptide cleaved from PAT1-EGFP, we performed a Tricine-SDS/PAGE experiment with the PAT1 antibody, but it failed. Perhaps this peptide (< 56 amino acids) was quickly degraded and thus, escaped detection. This may explain why the cleavage was not observed in previous studies by checking either the endogenous PAT1 [5] (the antibody was raised against an N-terminal peptide of PAT1), or ectopic PAT1 fused with a short Myc tag [17] .
In an attempt to explore the properties of the cleavage enzyme, we fed the EGFP-PAT1-expressing cells with EDTA, which is a metal ion chelator. We found that the cleavage was suppressed by the EDTA treatment (see Fig. S2 ). This indicates that the cleavage reaction is sensitive to metal ions and is probably catalysed by a metalloproteinase.
Mapping an N-terminal cutting motif on EGFP-PAT1
Many newly synthesized polypeptides possess signal sequences that are important to retain them within the endoplasmic reticulum (ER) to complete protein folding and other post-translational modifications. These signals are usually removed by special signal peptidases before the mature proteins can be delivered to their destinations [25] . However, the N-terminal cleavage of EGFP-PAT1 unlikely belongs to this type of regulation, because we have detected the full-length EGFP-PAT1 on the lysosome [19] . This means that at least some EGFP-PAT1 proteins functioning on the lysosome are not cleaved.
Site-specific cleavage is a common mechanism to regulate protein properties, such as stability, activity and localization. We wondered whether the N-terminal cleavage of EGFP-PAT1 plays any of these roles. We began to address this question by mapping the cutting motif. First, we constructed a new transgene, EGFP-PAT1 , which encodes a truncated protein spanning the first two cytosolic and three transmembrane domains of PAT1 (residues 1-179, see Fig. 1A ). When this transgene was transiently expressed in HEK293 cells, we detected the full-length EGFP-PAT1 (~48 kDa) and the cleaved~32 kDa fragment ( Fig. 2A) in western blot experiment. This means that the N-terminal 179-amino acid region contains all the essential sequences that can be recognized by the cleavage enzyme. Next, we transiently expressed a series of truncated EGFP-PAT1 1-179 proteins. We found that when the first 47 amino acids of PAT1 were removed, thẽ 32 kDa band was missing (Fig. 2B, upper panel,  lane4) . This implies that the left boundary of the cutting motif is threonine 47. 
(D) Stable cells expressing either EGFP-PAT1 or EGFP-PAT1
Y38A were starved for 1 h (AA, ÀFBS). After that, the whole cell lysates or purified lysosomes were analysed by western blot using the indicated antibodies. LAMP1 is a lysosomal protein. To quantify the relative abundance of lysosomal expression, the level of PAT1 on the lysosome was normalized to whole PAT1, using LAMP1 as a reference, and reported as arbitrary units. The error bars represent the mean AE SEM of three independent experiments. **P < 0.01.
To characterize the right boundary of the cutting motif, we constructed a PAT1 -EGFP transgene, in which the first 56-amino acid fragment of PAT1 was placed upstream of EGFP. From the western blot result, we observed two protein bands; including the full-length PAT1 -EGFP (~32 kDa) and thẽ 27 kDa EGFP tag (Fig. 2B, lower panel, lane 6 ). This means that the minimal cutting motif is located within the N-terminal 56-amino acid fragment. Then, we gradually removed amino acids from the C terminus of the first 56-amino acid fragment. Western blot results revealed that the right boundary of the cutting motif is phenylalanine 50 (Fig. 2B, lower panel) . Taken together, these results demonstrate that EGFP-PAT1 is cleaved around a four-amino acid motif in the N-terminal region of PAT1, 47 TTWF 50 . A sequence alignment revealed that the TTWF motif is highly conserved in the N terminus of PAT1 in vertebrates (Fig. S3) . We found that the EGFP-tagged mouse PAT1 (EGFP-mPAT1) could be processed to generate a similar~32-kDa fragment when it was transiently expressed in HEK293 cells (Fig. S3) . However, additional experiments must be performed to determine if PAT1 can be cleaved around the 'TTWF' motif in other types of cells and organisms.
The cleaved PAT1 region contains a tyrosinebased lysosomal targeting signal
We carefully analysed amino acid sequence close to the N-terminal side of the 47 TTWF 50 motif, searching for signals that may predict the significance of the cleavage. This led to the identification of a consensus tyrosine-based lysosomal targeting signal, 38 YQRF 41 (Fig. 2C) . It belongs to the YxxØ type, in which x is variable and Ø is a hydrophobic residue. This kind of signal is usually located in the cytosolic tails and can mediate protein movement from the trans-Golgi network (TGN) and/or the cell surface into endosomes that eventually will fuse with the lysosome [26, 27] .
To investigate the roles of the 38 YQRF 41 motif, we generated stable cell lines expressing EGFP-PAT1 Y38A , in which the critical 38 th tyrosine was replaced by an alanine (Y38A, see Fig. 2C ). This mutation disrupts the YxxØ signal and inhibits the transport of several membrane proteins to the lysosome, including two lysosomal surface markers, LAMP1 and LAMP2 [27, 28] . To examine if the Y38A mutation affects the lysosomal localization of EGFP-PAT1, we isolated lysosomes through cell fractionation, followed by western blot experiments to quantify the lysosomeanchored proteins. It has been shown that starvation can recruit PAT1 to the lysosome [19] . So we starved cells for 1 h before harvesting. Following such treatment, we detected a considerable amount of EGFP-PAT1 Y38A on the lysosome. However, compared with the wild-type EGFP-PAT1, the relative abundance of lysosome-associated EGFP-PAT1 Y38A was significantly reduced (Fig. 2D) . This result reveals that the YQRF motif assists the transport of EGFP-PAT1 to the lysosome.
The Y38A mutation impairs the function of PAT1 to inhibit mTORC1
Since EGFP-PAT1
Y38A cannot be efficiently delivered to the lysosome, we speculated that it might be less potent than the wild-type protein to inhibit mTORC1. This hypothesis was confirmed by the following experiments.
We examined the mTORC1 activities in several cell populations, including control HEK293 cells and stable cell lines expressing EGFP-PAT1 or EGFP-PAT1
Y38A
. All these cells were starved for 1 h, followed by restimulation with complete medium for 10 min. After that, the whole lysates were examined by western blot to check pS6K1 and p4EBP1, two specific markers of mTORC1 activity. Compared with control HEK293 cells, mTORC1 activity was decreased in EGFP-PAT1-expressing cells, which was revealed by decreased levels of both pS6K1 and p4EBP1. Interestingly, mTORC1 activity was either unchanged or even slightly increased in the cells expressing EGFP-PAT1 Y38A (Fig. 3A) . To obtain additional evidence of this finding, we also analysed mTORC1 activates in HEK293 cells transiently expressing the myc-tagged PAT1 proteins, including myc-PAT1 and myc-PAT1 Y38A . We found that mTORC1 activity was decreased in the cells expressing myc-PAT1, which was consistent with a previous report [17] , In contrast, overexpressing myc-PAT1 Y38A did not inhibit mTORC1 (Fig. 3B ). These results demonstrate that the Y38A mutation decreases the activity of PAT1 in mTORC1 inhibition.
The YQRF motif regulates the cell surface expression of EGFP-PAT1 EGFP-PAT1 has been shown to be expressed on both the lysosome and plasma membrane in HEK293 cells [20] . Since EGFP-PAT1
Y38A was poorly associated with the lysosome under starvation conditions, we suspected that it might be translocated to the cell surface.
To test this hypothesis, we labelled cell surface proteins with biotin and then checked the biotinylated proteins via western blot. The results revealed that starvation decreased the cell surface expression of both wild-type EGFP-PAT1 and EGFP-PAT1 Y38A (Fig. 3C , compare open and black columns in the quantification assay), but the decrease was less pronounced for EGFP-PAT1 Y38A (Fig. 3C) . We propose that the YQRF motif modulates the distribution of EGFP-PAT1 on the cell surface and the lysosome.
Amino acids are a signal to induce EGFP-PAT1 cleavage
The above results suggest that the cleavage of EGFP-PAT1 is probably a controlled process through which the cells adjust the lysosome expression of EGFP-PAT1. Inspired by the finding that amino acid deprivation increased the lysosome-associated EGFP-PAT1, we suspected that amino acids might be a signal to regulate EGFP-PAT1 cleavage.
To explore this possibility, we measured the cleavage of EGFP-PAT1 in a stable cell line cultured with either complete or starvation medium. Interestingly, we found that the cleavage rate (monitored by the ratio of the cleaved~32 kDa fragment/beta-actin) was gradually decreased as the starvation continued (Fig. 4A) . Once the starvation medium was replaced with complete medium for as short as 30 min, the cleavage rate was increased to a level similar to the unstarved cells (Fig. 4B) . Notably, the complete inhibit mTORC1. Cells were starved (ÀAA, ÀFBS) for 1 h, followed by incubation in complete medium for 10 min. After that, the whole cell lysates were analysed by western blot using the indicated antibodies. The mTORC1 activity was measured by two specific markers, including pS6K1 and p4EBP1. The quantification of the data, including the relative abundance of pS6K1 (pS6K1/S6K1) and p4EBP1 (p4EBP1/4EBP1), is reported as the mean AE SEM, of three repeated experiments; **P < 0.01. EGFP-PAT1 and EGFP-PAT1 Y38A (in A) were stably expressed; myc-PAT1 and myc-PAT1 medium used in these experiments contains FBS, which is absent in the starvation medium. To investigate whether FBS plays a role in EGFP-PAT1 cleavage, we stimulated the starved cells with individual amino acids (no FBS), including PAT1's preferred substrates (glycine, proline and alanine) [3] [4] [5] [6] [7] and potent mTORC1 stimulators (leucine, arginine and glutamine) [14] . We found that the supplementation with glutamine stimulated EGFP-PAT1 cleavage to a similar extent as complete medium (Fig. 4C ). These data suggest that amino acids are a signal to induce EGFP-PAT1 cleavage.
Amino acids may regulate EGFP-PAT1 cleavage via the direct substrate-transporter interaction
Because amino acids are a signal to activate mTORC1, it is possible that amino acids may indirectly stimulate EGFP-PAT1 cleavage via mTORC1. We treated the cells with rapamycin, a specific mTORC1 inhibitor, and found that suppression of mTORC1 had little influence on EGFP-PAT1 cleavage (Fig. 5A ). This implies that amino acids do not use the activation of mTORC1 to regulate EGFP-PAT1 cleavage. Alternatively, amino acids might directly bind with EGFP-PAT1 to induce the cleavage reaction. To test this hypothesis, we investigated whether the amino acid-loading mutants of PAT1 can be cleaved and whether the cleavage is still sensitive to amino acids. To this end, we generated cell lines stably expressing either EGFP-PAT1 C180A or EGFP-PAT1 C180/329A . Both kinds mutations destroyed the internal disulphide bond of PAT1 (formed between Cys-180 and Cys-329) and strongly inhibited the binding of amino acids to PAT1 [24] .
We found that, with complete medium, both EGFP-PAT1 C180A and EGFP-PAT1 C180/329A could be proteolysed to generate the~32 kDa fragment. However, the cleavage was not suppressed by amino acid deficiency (Fig. 5B,D) . We suspect that the disruption of the disulphide bond may expose the cutting site to the cleavage enzyme. These results suggest that the loading with amino acids affects EGFP-PAT1 cleavage. Consistent with this, the cleavage of EGFP-PAT1 , which lacks the putative amino acid-binding domain, was not sensitive to amino acids any more (Fig. 5B,  D) . The Y38A mutation is located in the cytosolic Nterminal domain. Theoretically, EGFP-PAT1
Y38A
should have a normal substrate-binding ability. We found that the cleavage of EGFP-PAT1 Y38A was still suppressed by amino acid deficiency (Fig 5C,D) . Taken together, these results suggest that amino acids may regulate EGFP-PAT1 cleavage via the direct substrate-transporter interaction. 
Discussion
Proton-coupled amino acid transporter 1 is commonly associated with the lysosome in various cell types and is believed to play an important role in both nutrient homoeostasis and mTORC1 regulation. However, little is known about how PAT1 proteins are localized on the lysosome surface. In this work, we provide evidence that the cytosolic N terminus of PAT1 contains a lysosomal targeting signal, ' 38 YQRF 41 ' . We found that a mutation in the critical tyrosine residue (Y38A) decreased the lysosome expression of EGFP-PAT1. Meanwhile, the cell surface expression of the mutated protein was increased. Consistent with these findings, we found that the overexpression of the Y38A mutants, including EGFP-PAT1
Y38A and myc-PAT1
Y38A
, failed to inhibit mTORC1. Because the Y38A mutation is located in the cytosolic tail, the mutant proteins should have intact substrate binding and transport functions. Therefore, the altered subcellular localization is a reasonable explanation of why the Y38A mutants did not inhibit mTORC1. It should be noted that the Y38A mutation decreased, but did not completely block the lysosomal An interesting finding of our previous work is that amino acids suppress the expression of EGFP-PAT1 on the lysosome in HEK293 cells. Here, we provide evidence that this can be at least partially explained by a post-translational mechanism, which means that EGFP-PAT1 can be cleaved to lose the YQRF lysosomal targeting motif. This process probably requires conformational changes of EGFP-PAT1, which are induced by amino acid loading (especially glutamine). We propose that the interaction between glutamine and EGFP-PAT1 may be sufficient to expose the cutting site, although the altered protein conformation does not allow efficient transport of glutamine across membranes [3] [4] [5] [6] [7] . We noticed that even cultured with complete medium, there is still a significant amount of EGFP-PAT1 proteins on the lysosome. This indicates that amino acids have a limited influence on the lysosomal expression of EGFP-PAT1, which is consistent with our prediction that PAT1 contains additional lysosomal targeting signals. Moreover, since PAT1 has diverse subcellular localizations in various cell types, it remains to be investigated if amino acids can regulate the localization of PAT1 in other systems.
In yeast, the localization of the general amino acid transporter Gap1p is dependent on nutrient supply. With a glutamate medium, Gap1p was expressed on the cell surface; with urea medium, Gap1p was transported to the yeast lysosome-like vacuole [29] . Thus, it seems to be a common phenomenon that nutrients modulate the subcellular localization of membrane transporters. However, it is not clear if nutrients regulate Gap1p localization through a similar post-translational mechanism of PAT1 in HEK293 cells.
To summarize, we propose a provisional model. When the amino acid supply is limited, there is more full-length PAT1 delivered to the lysosome where PAT1 promotes nutrient recycling and inhibits mTORC1. Both processes are critical for cells to survive under starvation conditions. On the other hand, the supplementation of amino acids induces PAT1 cleavage to remove the YQRF motif. Such cleavage can prevent the further accumulation of PAT1 on the lysosome. Eventually, the level of lysosomal amino acids is elevated, and mTORC1 is activated.
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